PRTK - Paratek Pharmaceuticals Inc.
Close
2.23
2.230 100.000%
Share volume: 0
Last Updated: Wed 20 Sep 2023 07:59:53 PM CEST
Pharmaceutical Preparation Manufacturing :
2.72%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
32%
Profitability
43%
Dept financing
50%
Liquidity
32%
Performance
18%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2019 - 30-Jun-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
24.6%
Return on assets
-7.84%
Return on sales
-134.6%
Return on invested capital
-930.31%
Total debt ratio
167.53%
Debt ratio change over timeo
1.06%
Current Ratio
5.64%
Quick Ratio
5.19%
Cash Position Ratio
3.98%
Short-term ratios 30-Jun-2022 - 30-Jun-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
8.66%
Return on assets
-7.27%
Return on sales
-33.12%
Return on invested capital
210.99%
Total debt ratio
217.05%
Debt ratio change over timeo
5.62%
Current Ratio
2.67%
Quick Ratio
2.31%
Cash Position Ratio
0.99%
Last quarter ratios 30-Jun-2023
The data are presented for the financials results of the last quarter.
Return on equity
7.23%
Return on assets
-6.46%
Return on sales
-23.53%
Return on invested capital
8.98%
Total debt ratio
238.12%
Debt ratio change over time
25.52%
Current Ratio
0.52%
Quick Ratio
0.46%
Cash Position Ratio
0.21%
Performance ratios (change over 4 years) 30-Jun-2019 - 30-Jun-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-78.92%
Return on assets
-107.18%
Return on sales
-207%
Return on invested capital
7.47%
Total debt ratio
105.95%
Debt ratio change over time
1.06%
Current Ratio
1.98%
Quick Ratio
1.78%
Cash Position Ratio
1.36%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | PRTK | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 24.6% | 0% | 0% | -106.57% |
| Return on assets | -7.84% | 0% | 0% | -12.17% |
| Return on sales | -134.6% | 0% | 0% | -8133.27% |
| Return on invested capital | -930.31% | 0% | 0% | -41.1% |
| Profitability | 25% | 0% | 75% | 0% |
| Total debt ratio | 167.53% | 0% | 0% | 80.46% |
| Debt ratio change over time | 1.06% | 0% | 0% | -0.75% |
| Dept financing | 50% | 0% | 0% | 12% |
| Current Ratio | 2.67% | 0% | 0% | 6.21% |
| Quick Ratio | 2.31% | 0% | 0% | 6.2% |
| Cash Position Ratio | 0.99% | 0% | 0% | 5.92% |
| Liquididy | 49% | 0% | 0% | 75% |
| Short-term ratios | PRTK | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 8.66% | 0% | 0% | -327.32% |
| Return on assets | -7.27% | 0% | 0% | -17.01% |
| Return on sales | -33.12% | 0% | 0% | -23351.25% |
| Return on invested capital | 210.99% | 0% | 0% | -301.3% |
| Profitability | 50% | 0% | 50% | 0% |
| Total debt ratio | 217.05% | 0% | 0% | 105.86% |
| Debt ratio change over time | 5.62% | 0% | 0% | -1.68% |
| Dept financing | 50% | 0% | 0% | 12% |
| Current Ratio | 2.67% | 0% | 0% | 6.21% |
| Quick Ratio | 2.31% | 0% | 0% | 6.2% |
| Cash Position Ratio | 0.99% | 0% | 0% | 5.92% |
| Liquididy | 24% | 0% | 0% | 75% |